Journal of Pharmaceutical and Biomedical Analysis
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q2 | 60.1% | 0.604 | Q2 | 67.9% |
| 2024 | 3.1 | Q2 | 62.3% | 0.628 | Q2 | 69.9% |
| 2023 | 3.1 | Q2 | 65.9% | 0.584 | Q2 | 70.0% |
| 2022 | 3.4 | Q2 | 62.5% | 0.608 | Q2 | 72.4% |
| 2021 | 3.6 | Q3 | 60.3% | 0.657 | Q2 | 75.7% |
| 2020 | — | — | 0.777 | Q1 | 79.1% | |
| 2019 | — | — | 0.795 | Q1 | 80.2% | |
| 2018 | — | — | 0.786 | Q1 | 78.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1873-264X
ISSN
0731-7085
country
NLcoverage
1983-2026